What To Know About Adcetris—Pfizer's Cancer Drug Extended Survival For Patients With Common Lymphoma

ToplinePfizer’s cancer drug Adcetris extended survival in patients with a common form of lymphoma in a late-stage trial, the company announced Tuesday, supporting Pfizer’s efforts to expand into cancer treatments amid declining Covid vaccine sales.The drugmaker invested in cancer drugs last year amid declining Covid vaccine sales. Getty Images Key FactsPatients with diffuse large B-cell lymphoma showed a “statistically significant and clinically meaningful improvement” in overall survival—the amount of time ...